Neural Probe-Based Solutions for Environmental, Agricultural, Athletic, Cybersecurity, and Dermatological Applications

Publication ID: 24-11857326_0002_PTD
Published: November 07, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Neural Probe-Based Solutions for Environmental, Agricultural, Athletic, Cybersecurity, and Dermatological Applications,” Published Technical Disclosure No. 24-11857326_0002_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857326_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,326.

Summary of the Inventive Concept

This inventive concept leverages the core technology of agent-delivering neural probes to address diverse, high-impact problems across various industries, including environmental pollution, agricultural crop yields, athletic performance, cybersecurity, and skin conditions.

Background and Problem Solved

The original patent's agent-delivering neural probes were designed for neurological treatment devices, but their limitations in terms of profile thickness and potential brain tissue damage during use can be overcome by applying this technology to entirely new fields. The new inventive concept solves the problem of finding innovative solutions to pressing challenges in these industries.

Detailed Description of the Inventive Concept

The inventive concept involves adapting the agent-delivering neural probes to detect and respond to specific stimuli in various applications. For instance, in environmental monitoring, the probes can detect pollutants and release remediation agents. In agriculture, they can detect soil nutrient deficiencies and release nutrient-rich agents. In athletic performance, they can detect physiological signals and release performance-enhancing agents. In cybersecurity, they can monitor network activity and release security-enhancing agents in response to suspicious activity. In dermatology, they can detect skin irritation and release soothing agents.

Novelty and Inventive Step

The new claims introduce a paradigm shift by applying the core technology to entirely new industries, which is non-obvious and novel compared to the original patent's focus on neurological treatment devices. The inventive step lies in recognizing the potential of agent-delivering neural probes to address diverse, high-impact problems and adapting the technology to meet the specific needs of each application.

Alternative Embodiments and Variations

Alternative embodiments may include using different types of agents, varying the probe's design and materials, or integrating the probes with other technologies, such as AI, IoT, or robotics, to enhance their functionality and applicability. Variations could include using the probes for other applications, such as monitoring and responding to natural disasters or detecting and mitigating the effects of climate change.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential across multiple industries, including environmental monitoring, agriculture, athletic wearables, cybersecurity, and dermatological treatments. The market potential is substantial, with opportunities for partnerships, licensing, and product development in each of these areas.

Field of Art

Biomedical engineering, neural interface technologies, and agent delivery systems with expertise in probe design, material science, and targeted therapeutic interventions

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or bioengineering researcher with advanced degrees, knowledge of neural probe technologies, material dissolution mechanisms, and experience in designing minimally invasive medical devices with agent delivery capabilities

Obviousness Rationale

A PHOSITA would recognize the fundamental adaptability of the neural probe's core technology - a dissolvable scaffold capable of targeted agent delivery - as inherently transferable across multiple domains. The source patent's core innovation of a responsive, agent-releasing probe provides a clear technological template that can be systematically modified for different environmental and functional contexts. The PTD's variations represent predictable extensions of the original probe technology by simply changing the detection parameters and agent composition.

Obvious Combinations & Variations

Source Patent Element
Dissolvable scaffold with agent delivery mechanism
PTD Variation
Adapting probe to detect environmental pollutants and release remediation agents
Obviousness Reasoning
Known technique of modifying probe's sensing and agent release parameters to match specific detection requirements, representing a predictable design variation
Source Patent Element
Neural probe configured to detect physiological signals
PTD Variation
Repurposing probe for agricultural monitoring of soil nutrient deficiencies
Obviousness Reasoning
Predictable application of signal detection and targeted agent release mechanism to alternative sensing domain with finite, identifiable solution set
Source Patent Element
Treatment agent release over predetermined time period
PTD Variation
Performance-enhancing agent delivery in athletic performance monitoring
Obviousness Reasoning
Straightforward adaptation of existing time-controlled release mechanism to different physiological intervention context
Source Patent Element
Configurable agent delivery structure for neurological intervention
PTD Variation
Cybersecurity network monitoring with security agent release
Obviousness Reasoning
Obvious extension of probe's core signal detection and responsive agent delivery principle to information security domain
35 U.S.C. § 103 Summary: Based on US Patent 11857326's teachings of an agent-delivering neural probe with dissolvable scaffold technology, a person having ordinary skill in the art would find the variations disclosed herein to be obvious modifications representing predictable technological extensions. The fundamental probe architecture and agent delivery mechanism remain substantially unchanged, with variations primarily involving alternative sensing parameters and agent compositions, thus rendering subsequent claims obvious under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,326
TitleAgent-delivering neural probe devices and related systems and methods
Assignee(s)NeuroOne Medical Technologies Corporation